Using genetic and pharmacological approaches to modulate CD47 signalling capability, we reveal that CD47 inhibition improves anti-apoptotic, senescence, autophagic and self-renewal responses to hypoxia, hyperglycaemia or ER stress in MIN6 cells, as well as primary mouse and human islets. The gene discussed is CD47; the disease is Hyperglycemia.